KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Non-Current Assets (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Non-Current Assets for 4 consecutive years, with $884.5 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Non-Current Assets rose 116.43% year-over-year to $884.5 million, compared with a TTM value of $4.1 billion through Sep 2023, up 185.27%, and an annual FY2022 reading of $1.1 billion, up 213.05% over the prior year.
  • Non-Current Assets was $884.5 million for Q3 2023 at Ginkgo Bioworks Holdings, down from $1.1 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.7 billion in Q1 2021 and bottomed at $248.6 million in Q4 2020.
  • Average Non-Current Assets over 4 years is $843.6 million, with a median of $884.5 million recorded in 2023.
  • Peak annual rise in Non-Current Assets hit 213.05% in 2022, while the deepest fall reached 79.6% in 2022.
  • Year by year, Non-Current Assets stood at $248.6 million in 2020, then surged by 39.96% to $347.9 million in 2021, then surged by 213.05% to $1.1 billion in 2022, then decreased by 18.79% to $884.5 million in 2023.
  • Business Quant data shows Non-Current Assets for DNA at $884.5 million in Q3 2023, $1.1 billion in Q2 2023, and $1.1 billion in Q1 2023.